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DOI: 10.1039/c0sc00271bGlycosaminoglycans are sulfated polysaccharides that play important roles in fundamental biological
processes, such as cell division, viral invasion, cancer and neuroregeneration. The multivalent
presentation of multiple glycosaminoglycan chains on proteoglycan scaffolds may profoundly influence
their interactions with proteins and subsequent biological activity. However, the importance of this
multivalent architecture remains largely unexplored, and few synthetic mimics exist for probing and
manipulating glycosaminoglycan activity. Here, we describe a new class of end-functionalized
ring-opening metathesis polymerization (ROMP) polymers that mimic the native-like, multivalent
architecture found on chondroitin sulfate (CS) proteoglycans. We demonstrate that these
glycopolymers can be readily integrated with microarray and surface plasmon resonance technology
platforms, where they retain the ability to interact selectively with proteins. ROMP-based
glycopolymers are part of a growing arsenal of chemical tools for probing the functions of
glycosaminoglycans and for studying their interactions with proteins.Fig. 1 (A) Structures of representative GAG classes. R ¼ SO3 or H;
R1 ¼ SO3, H, or Ac; n ¼ 10–200. (B) Schematic representation of
a proteoglycan, which typically consists of multiple GAG chains attached
to a protein core. (C) Biotin end-functionalized ROMP polymers as
mimetics of CS proteoglycans. n ¼ 80–280.Introduction
Carbohydrates possess greater structural diversity than either
nucleic acids or proteins. Although they participate in a wide
range of critical processes and alterations in their structure have
been linked to a number of human diseases, they remain under-
explored targets for chemical biology and pharmaceutical
chemistry. We have embarked on a program to study a large class
of sulfated polysaccharides known as glycosaminoglycans, with
the goals of understanding their structure–function relationships
and gaining insight into the molecular mechanisms underlying
their biological activity.
Glycosaminoglycans (GAGs) are polymers, composed of
10–200 repeating sulfated disaccharide units (Fig. 1A).1 GAGs
contain regions of high and low sulfation,2 with highly sulfated
regions serving as binding sites for proteins.3 These protein
interactions endow GAGs with the ability to regulate essential
processes such as cell division, viral invasion, blood coagulation
and neuronal regeneration.1a,b,3a,4 GAGs are covalently attached
to various proteoglycan proteins, with some proteoglycans
bearing as many as 100 sugar chains (Fig. 1B).5 It has been
established using synthetic glycopolymers and oligosaccharides
for other systems that the relative position and density of sugars
can impact the avidity and specificity of glycan–protein interac-
tions.6 However, despite these important advances, the role of
the multivalent architecture found in native GAG structures has
remained largely unexplored.Division of Chemistry and Chemical Engineering and Howard Hughes
Medical Institute, California Institute of Technology, Pasadena,
California, 91125, USA. E-mail: lhw@caltech.edu; Fax: +1 626 564
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322 | Chem. Sci., 2010, 1, 322–325Here, we describe a new class of end-functionalized GAG
mimetic glycopolymers that are designed to mimic the multi-
valent presentation of chondroitin sulfate (CS) on proteoglycans.
We demonstrate that these glycopolymers can be integrated with
microarray as well as surface plasmon resonance (SPR) tech-
nology platforms to probe GAG–protein interactions and study
the activity of specific sulfation motifs.This journal is ª The Royal Society of Chemistry 2010
Table 1 Generation of CS Glycomimetics Using ROMP
entry monomer
mol %
catalyst polymer n (DP) % yield
Mn
a/g
mol1 PDIa
1 3 1.0 9 97 87 105,100 1.17
2 3 0.5 10 281 92 283,100 1.07
3 3 1.0 1 86 74b 68,480 1.05
4 7 1.0 15 82 55b 48,480 1.10
a Number average molecular weight and polydispersity index were
determined by GPC (0.2 M LiBr in DMF for entries 1–2; 100 mM
NaNO3 and 200 ppm NaN3 in water for entries 3–4).
b Yield for 3
steps (polymerization, desilylation, saponification).
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View OnlineResults and discussion
To mimic the orientation of the sugar chains on proteoglycans,
we designed glycopolymer 1, which has an end-functionalized
biotin moiety to achieve the desired orientation of the pendant
sugars and to facilitate attachment of the polymer to surfaces
(Fig. 1C). We chose a norbornene-based backbone to allow for
multivalent display of the sugar chains at defined, chemically
controlled intervals and to confer a degree of rigidity to the
structure. Previous studies in our laboratory have demonstrated
that glycopolymers containing complex, highly anionic di- and
tetrasaccharides can be generated using ring-opening metathesis
polymerization (ROMP) chemistry, although more flexible cis-
cyclooctene monomers were employed.7 In addition to increasing
the structural rigidity of the resultant polymer, norbornene-
based monomers would have the advantage of enabling access to
block copolymers for controlling the sulfation motifs between
GAG chains.
Glycopolymer 2 was synthesized from monomer 3, which
contains the biologically active CS-E disaccharide unit (Scheme
1).8 Briefly, trichloroacetimidate donor 4 was coupled to nor-
bornene acceptor 5 to provide fully protected disaccharide 6 in
good yield and with excellent b-stereoselectivity. Radical–medi-
ated conversion of the N-trichloroacetyl group to an N-acetyl
group and DDQ oxidation of the p-methoxybenzylidene acetal
afforded diol 7. Sulfation using sulfur trioxide$trimethylamine
complex afforded the desired norbornene monomer 3 in 83%
yield. A major challenge for the polymerization reaction was the
low solubility of sulfated oligosaccharides in the non-coordi-
nating, aprotic solvents typically used for ROMP. Fortunately,
the fully protected, sulfated monomer 3 was soluble in MeOH/
(CH2Cl)2 co-solvent mixtures, and polymerization with 1.0 mol%
of Grubbs’ catalyst (H2IMes)(Py)2(Cl)2Ru ¼ CHPh (8)9 led to
complete conversion to the desired glycopolymer 9 within 5 min
(Table 1, degree of polymerization (DP) ¼ 97; polydispersity
index (PDI) ¼ 1.17). Lowering the catalyst concentration to
0.5 mol% produced glycopolymer 10 with exceptionally long
chain lengths (DP ¼ 281; PDI ¼ 1.07). Longer polymers with
narrower polydispersities were attainable with norborneneScheme 1 Synthesis of Norbornene-based CS Glycopolymers
This journal is ª The Royal Society of Chemistry 2010relative to cis-cyclooctene monomers,7,10 which may be advan-
tageous for biological activity. The CS glycomimetics 2 and 11
were obtained after desilylation and sequential LiOOH–NaOH
treatment in 71–80% yield over two steps.
We next investigated end-functionalization of the glycopoly-
mers with a biotin moiety. Previous studies have established that
internal cis-olefin or enol ether terminating agents (TA) can be
used for the direct, efficient capping of ROMP polymers.11
Addition of the biotin terminating agent 1211b to the reaction
mixture after completion of the living polymerization, resulted in
the desired end-capping of the glycopolymer to produce
13 (Scheme 2). Desilylation and saponification afforded
glycopolymer 1 in 74% overall yield over the 3 steps (Table 1,
DP ¼ 86; PDI ¼ 1.05). The end-capping efficiency of 20%, as
determined using a colorimetric biotin quantification assay and
1H NMR, was modest due to the limited solubility of the
unquenched glycopolymer and 12. For comparison, we also
synthesized the biotin-functionalized unsulfated glycopolymer 15
(DP ¼ 82; PDI ¼ 1.10) from monomer 7 using a similar
approach.
To explore the ability of the glycopolymers to interact with
protein receptors, glycopolymers 1 and 15 were attached to
microarray surfaces. A high-precision contact-printing robot was
used to deliver nanoliter volumes of the biotin-labeled glyco-
polymers to streptavidin-coated slides, yielding spots approxi-
mately 200 mm in diameter. We examined the binding of
monoclonal antibodies 2D11 and 2D5, which are selective for the
CS-E and CS-C sulfation motifs, respectively.3b,8a The micro-
arrays were incubated with each antibody (70 nM), and protein
binding was visualized using a secondary Cy3-conjugated goat
anti-mouse antibody. Antibody 2D11 bound selectively to CS-E
sulfated glycopolymer 1 and showed no detectable binding toScheme 2 Synthesis of Biotin End-Functionalized CS Glycopolymers
Chem. Sci., 2010, 1, 322–325 | 323
Fig. 2 (A) Binding of the CS-E Ab (left) and CS-C Ab (right) to CS-E
glycopolymer 1 and unsulfated glycopolymer 15 immobilized on micro-
arrays. (B) Binding of GDNF to glycopolymers 1 and 15. Each micro-
array contained 640 spots, and the bar graphs represent the
quantification for selected concentrations of glycopolymer (1280 data
points per protein). The inset shows binding of the CS-E Ab to 1 on
a representative portion of the array. See Supplementary Information†
for details.
Fig. 3 Surface plasmon resonance of GDNF binding to CS glycopoly-
mers 1 and 15. GDNF at varying concentrations (2, 1, and 0.5 nM) binds
to the CS-E sulfated glycopolymer (red), but not the unsulfated polymer
(black). (B) The dissociation constant (KD) for the interaction between 1
and GDNF was measured by plotting the response at equilibrium for
varying concentrations of GDNF. Nonlinear regression analysis gave
a KD of 6  1 nM.
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View Onlineunsulfated glycopolymer 15 (Fig. 2A). Moreover, no binding of
the CS-C antibody 2D5 to either glycopolymer was observed,
consistent with the selective recognition of specific sulfated
epitopes. We also examined the binding of several growth
factors, including glial cell-derived neurotrophic factor (GDNF),
a growth factor important for the survival and differentiation of
dopaminergic neurons.12 Although the binding of GDNF to
a highly sulfated mixture of chondroitin and dermatan sulfate
chains has been studied,3c its ability to recognize homogeneous,
well-defined CS structures has not been explored. Significant
binding of GDNF to the CS-E glycopolymer, but not the
unsulfated glycopolymer, was observed (Fig. 2B), indicating
a clear preference of GDNF for the sulfated sugar epitope.
Finally, we investigated whether the end-functionalized
glycopolymers could be used to facilitate quantitative, real-time
analysis of GAG–protein interactions using surface plasmon
resonance (SPR). Glycopolymers 1 and 15 were immobilized on
streptavidin–conjugated CM5 sensor chips at low density (RLz
25 RU) to prevent mass transfer-limited kinetics. Binding of
GDNF to the glycopolymers was assessed by flowing GDNF over
the chip at various concentrations (2, 1, 0.5 nM) and recording the
SPR sensorgrams (50 mL min1, 25 C). As shown in Fig. 3,
GDNF interacted with the CS-E sulfated glycopolymer, but not
with the unsulfated glycopolymer, consistent with the microarray
results. Binding of GDNF to glycopolymer 1 was characterized
by a slow initial rate of association that rapidly reached equilib-
rium, followed by a slow rate of dissociation. By plotting the
response at equilibrium for varying concentrations of GDNF
(0.25–62 nM), we obtained a dissociation constant (KD) of 6 
1 nM for the interaction between GDNF and glycopolymer 1. It is324 | Chem. Sci., 2010, 1, 322–325well known that monovalent CS and heparan sulfate disaccha-
rides exhibit weak binding affinity for proteins and minimal
biological activity.7,8b,13 Indeed, binding of GDNF to a bio-
tinylated CS-E disaccharide could not be detected under these
conditions (Fig. S2†). Thus, the observation that our glycopoly-
mers interact strongly with proteins suggests that the multivalent
display of sulfated epitopes between GAG chains plays a critical
role in enhancing their interactions with proteins. Together, our
studies demonstrate that end-functionalized ROMP glycopoly-
mers can effectively engage glycosaminoglycan-binding proteins
and function as novel mimetics for CS glycosaminoglycans.
Conclusions
We have generated a new class of CS glycomimetic polymers that
display defined sulfation motifs, while mimicking the multivalent
architecture of native GAG chains. Our studies demonstrate that
these glycopolymers can be efficiently attached to surfaces, where
they approximate physiological cell–cell and cell–extracellular
matrix interactions and retain the ability to engage proteins.
ROMP-based glycopolymers are part of a growing arsenal of
chemical tools for studying the structure–activity relationships of
GAGs. We anticipate that they will prove valuable for under-
standing how multivalency, not only within but also between,
GAG chains enhances the avidity, specificity and cooperativity of
GAG–protein interactions. Future studies will focus on extending
the methodology reported herein to polymers and block co-
polymers with varied sulfation patterns and applying them as
tools to manipulate CS activity in various biological contexts.
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